Method of Treating Kcnq Related Disorders Using Organozinc Compounds
申请人:Li Min
公开号:US20110257146A1
公开(公告)日:2011-10-20
The instant invention describes methods of treating KCNQ related diseases and disorders using organozinc compounds. In certain embodiments, pain is treated using Zinc Pyrithione.
[EN] METHOD OF TREATING KCNQ RELATED DISORDERS USING ORGANOZINC COMPOUNDS<br/>[FR] PROCEDE DESTINE A TRAITER DES TROUBLES LIES A KCNQ A L'AIDE DE COMPOSES ORGANOZINC
申请人:UNIV JOHNS HOPKINS
公开号:WO2007087424A2
公开(公告)日:2007-08-02
[EN] The instant invention describes methods of treating KCNQ related diseases and disorders using organozinc compounds. In certain embodiments, pain is treated using Zinc Pyrithione. [FR] La présente invention concerne des procédés destinés à traiter des pathologies et des troubles liés à KCNQ à l'aide de composés organozinc. Dans certains modes de réalisation, la douleur est traitée à l'aide de pyrithione de zinc.
A series of compounds forming polar crystals and showing single-crystal-to-single-crystal transitions between polar phases
samples. The imine obtained using acetone shows solid state polymorphism with unusual behaviour; three different crystal phases have been identified (phases I, II and III), all having the same polar space group Pna21, and the transitions from I to II and from III to II are topotactic, i.e. single-crystal-to-single-crystal. During the irreversible transition from phase I to II, the polar axis undergoes